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Purpose: To evaluate the use of the CoolSkin® (Elbio, Seoul, Korea) skin-cooling device to 
reduce injection pain during rhytidectomy.
Method: Nineteen patients underwent rhytidectomy using the CoolSkin at -4°C on the first 
side lateral injection. The second side was then started without the cooling. Patients were 
offered cooling if they desired it on the second side. Surveys were administered 24 hours after 
the procedure, comparing pain (scale 0–5) and investigating treatment preferences. Patient 
healing was tracked for 6 weeks.
Results: Mean pain score for the untreated side was 4.63 versus 2.37 for the CoolSkin-treated 
side (P , 0.001). All patients asked for the second side to be cooled, and 89% were in favor 
of the chilling procedure when surveyed 24 hours afterwards. Sixty eight percent of patients 
stated that this device reduced fear of future injections. No flap loss or healing sequelae were 
noted from device use.
Conclusion: The CoolSkin device is an effective tool to reduce injection pain laterally during 
rhytidectomy.
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Introduction
While pain is a subjective feeling related to many physiologic and personal factors, 
fear of discomfort can be a large impediment to patients receiving esthetic procedures. 
Many adults experience anxiety when undergoing needle-based procedures.1 Topical 
anesthetics can be used to reduce pain with injectables,2 but such options can be prohibi-
tive when doing larger facial esthetic procedures; for example, using injected lidocaine 
as the topical may interfere with proper dosing calculations.3 In the last decade, there 
has been a shift towards performing facial esthetic procedures like face lifts with less 
invasive techniques. These techniques are often performed with less sedation and more 
regional blocks,4 bringing pain-control issues to the forefront.
Cooling the skin is one strategy that has been employed to reduce injection pain, 
as studies have shown that it changes sensory and motor-nerve conduction.5–10 While 
ice is not comparable with the application of topical anesthetic creams,11 it can be 
very effective in reducing pain thresholds during needle injections.12 Of the different 
modalities for cold application, ice massage more closely resembles reduced nerve 
sensory conduction velocities of cold water immersion than simple ice packs.13 
To this end, having a focalized and stable cooling source is paramount to proper 
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The CoolSkin® (Elbio, Seoul, Korea) is a skin-cooling 
device that uses the Peltier effect to focus thermoelectric 
refrigeration on a single metal paddle, maintaining a con-
stant temperature down to -16°C regardless of skin contact 
time and surface area touched by the paddle. The device 
has been shown to reduce injection pain for injectables like 
botulinum toxin.14 In this study, the effect of this device on 
reducing injection pain during rhytidectomy (face lift) was 
evaluated.
Patients and methods
Twenty-two patients undergoing a 5–6 cm flap-length rhyti-
dectomy (high-superficial muscular aponeurotic system 
with deep plane imbrications and medial platysmaplasty) 
consented to participate in the trial over a 3-month study 
period. Consents followed established good clinical practice 
guidelines. Nineteen patients underwent the treatment pro-
tocol and three patients were control patients. The surgical 
procedure began with the administration of oral valium, 
variably dosed from 15 to 20 mg. The patients were then 
marked for the stated rhytidectomy procedure, along with 
other supplemental procedures, such as neck liposuction, 
platysmaplasty, blepharoplasty, and fractional carbon dioxide 
laser resurfacing. The patients were mildly sedated at the 
start of the procedure and were able to converse and provide 
feedback for the injection process.
The procedure commenced with the patient getting the 
right side injected. The CoolSkin device was set to -4°C and 
the skin in the temporal and upper preauricular marked crease 
was cooled for a total of 5 seconds and then injected with 
0.25% bupivacaine hydrochloride (Marcaine; AstraZeneca 
plc, London, UK) with 1:100,000 epinephrine (Amphastar 
IMS Limited, South El Monte, CA). Bicarbonate buffer 
(Hospira Inc, Lakeforest, IL) was added to all injections. The 
remaining preauricular sulcus was then injected after subse-
quent skin cooling for 5 seconds. This injection proceeded 
into the postauricular sulcus and then along a hair-sparing 
incision line, using the same cooling and injection technique. 
A total of 10 mL of the bupivacaine hydrochloride mixture 
was injected initially. Then, using 0.5% lidocaine (Hospira 
Inc) with 1:200,000 epinephrine, the remaining marked flaps 
were injected, all with 5-second skin cooling of the surface 
area prior to injection. At this point, the patient’s head was 
turned so that the right injected side was facing down and 
the left uninjected side was facing upward. The second side 
proceeded with the temporal and upper preauricular crease 
injection being performed with 0.5% bupivacaine hydrochlo-
ride with 1:100,000 epinephrine but no chilling. After the 
first injection the patient was asked if they wanted to proceed 
without the chiller or if they wanted the injection done with 
chilling, similar to the right side. After the left side was 
injected, the central neck was injected. The laser procedures 
were performed at case end without the chiller.
Patients were then wrapped and discharged home and 
returned for a follow-up 24 hours later. At this point, the 
patients took a survey asking them to give a 0–5 analog 
pain score for the treated and untreated sides, whether they 
preferred treatment, and whether the experience would 
reduce fear of future injections. Data were then compiled and 
statistical analysis was performed using paired t-tests. The 
charts and photos were also viewed at 6 weeks to evaluate any 
wound healing or flap issues related to the procedure.
Finally, three patients were evaluated for future study 
designs. One patient had botulinum toxin (Botox®, Allergan, 
Irvine, CA) using a split forehead protocol, and two patients 
had central neck procedures only with no lateral injections. 
One patient had only central neck laser lipolysis, and another 
patient had a T-neck operation (a direct midline skin excision 
with platysmalplasty) in the central neck with laser lipolysis. 
In these two patients, the right half of the neck was chilled 
and the left half was not chilled during the injection. The 
patient who received botulinum toxin was asked the survey 
questions the day of the procedure, while the central neck 
procedure patients were asked the questions the day following 
their procedures.
Results
Of the 19 patients who underwent the CoolSkin procedure, 
there were 18 female and one male, with the mean age of all 
patients being 61.5 years. The three control patients were all 
female with a mean age of 64.7 years. Of the treated patients, 
all 19 asked that the chiller be applied to their skin during 
the second side injection. Table 1 lists each patient and their 
24-hour pain scores for the treated side and the untreated 
side before the request was made to apply the chiller.   Control 
patients all described injection pain as level 5 on both sides, 
while the study group described the average pain as 4.63 
(±0.83) on the untreated side. This score dropped to an aver-
age pain level of 2.37 (±1.6) on the treated side, which was 
statistically significant (Figure 1; P , 0.001). When asked if 
they preferred to be treated or untreated, 17/19 study patients 
preferred treatment, with the remaining two failing to answer 
the question (Table 2). One control patient answered that they 
preferred to be “treated”: this was an indication of their desire 
for discomfort reduction rather than an indication that they 
received any treatment. Patients were asked if the CoolSkin Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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Figure 1 Average pain score (±SD) on cooled side and unchilled side of treated 
patients.
Notes: Nineteen patients underwent a rhytidectomy using CoolSkin® on the first 
side lateral injection. The second side was started without chilling. Patients ranked 
pain on a scale of 0–5, comparing the chilled and unchilled sides. Average response 
of 19 treated patients is shown.
Abbreviation: SD, standard deviation.
Table 1 Pain scores after injections for facial aesthetic procedures
Patient Age Sex Diagnosis Cooled side score Control side score
1 67 F FL 4 5
2 64 M FL, PL 0 5
3 65 F FL, Lipo, PL 2 3
4 62 F FL, PL, CO2 5 5
5* 67 F FL, PL, Lipo, CO2 5 5
6 58 F FL, Lipo, PL, CO2 5 5
7 57 F FL, Lipo, PL, CO2 1 4
8* 71 F FL, Lipo, PL, CO2 5 5
9* 56 F FL, PL, CO2 5 5
10 59 F FL, CO2 1 2
11 57 F FL, Lipo, PL 1 5
12 71 F FL 2 5
13 47 F FL, Lipo, PL 2 4
14 64 F FL, PL, Ue, CO2 5 5
15 63 F FL, Lipo, PL 4 5
16 76 F FL, Lipo, PL 3 5
17 61 F FL, LaserLipo, PL 3 5
18 74 F FL, PL, Lipo 2 5
19 47 F FL, LaserLipo 1 5
20 61 F FL, PL, Laserlipo 3 5
21 55 F FL, PL, LaserLipo 0 5
22 60 F FL, PL, LaserLipo 1 5
Average (n = 19) 61.5 2.37 ± 1.6
4.63 ± 0.83
Notes: Nineteen patients underwent a rhytidectomy using CoolSkin® on the first side lateral injection. The second side was started without chilling. Patients ranked pain 
on a scale of 0–5 comparing the chilled and unchilled sides. Three patients (highlighted in bold and marked with an asterisk) experienced no chilling on either side of the face 
during their procedure. The mean age of the 19 study patients, along with their pain scores on 24-hour surveys, standard deviation, and paired t test between the treated 
and untreated sides is listed. Averages reflect only treated patients’ data. Paired t-test (P , 0.001). *Control patients (no chilling).
Abbreviations: FL, face lift; Lipo, liposuction; LaserLipo, laser liposuction; PL, platymalplasty; Ue, upper eye blepharoplasty; CO2, fractional carbon dioxide laser resurfacing; 
n, number.
use would reduce their fear of future injections, and 68% 
answered yes (Table 3).
All patient skin flaps were evaluated at 24 hours, 1, and 
6 weeks after the procedure, with no clinical evidence of flap 
loss or delayed skin healing.
Finally, three patients who had the CoolSkin treatment 
with nonface-lift procedures were evaluated (Table 4). The 
patient who received botulinum toxin had a diminution of 
pain, while the central neck–injected patients showed no 
difference in pain scores. All three patients preferred to have 
been treated with the CoolSkin device.
Comment
Industry data clearly show that “fear of discomfort both dur-
ing and after treatment” is a major reason why consumers 
remain undecided about undergoing cosmetic surgery.15 The 
trend toward more minimally invasive styles of face lifting, 
with patient desire for faster recovery, has made injection 
pain a significant potential impediment to modern facial 
plastic practices. To this end, this study was undertaken to 
evaluate newer techniques to reduce injection pain without 
complicating injection–dose toxicity risks.
During face-lift injections, distribution of the auricu-
lotemporal and great auricular nerve fibers make pre- and 
postauricular blocks especially painful. These are often the 
injections performed first and, from the authors’ experi-
ence, they are the ones most cited by patients as being 
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sistent temperature can reduce skin cooling efficacy in this 
area along with the discomfort of water condensation around 
the ear. The authors’ prior work using air-based chilling sys-
tems proved problematic as patients complained of cold air 
blowing around the ear canal as well as temperature regula-
tory problems and surface area cooling inconsistencies. The 
theory of “ice massage”13 seemed most compelling, leading 
the authors to further investigate the CoolSkin device.
The distinct advantage of this system was that the 
machine maintained a preset temperature that did not change 
as the hand piece contacted the skin. The skin thus cooled 
rapidly and consistently with minimal moisture being added 
to the field. The authors did not find the need to check 
skin temperatures with an infrared source, but, during the 
product evaluation, a period of 5 seconds was found to 
be adequate for the device cool the skin surface area to a 
reduced pain state. The temperature of -4°C was found to be 
a good temperature to minimize potential risk to flaps from 
over cooling. The follow-up data showed this to be a safe 
temperature for flaps. Future studies using infrared checks 
may find more ideal temperatures. Patients found the device 
comfortable with no specific complaints of discomfort using 
it around the ear.
The three control patients had the injections done without 
any chilling and they reported discomfort, all rating the pain 
as 5 in their surveys 24 hours later. Similarly, the study group 
patients rated the pain level average as 4.6, prior to all of them 
getting the remainder of the site of their second side injec-
tion chilled. The comparison of pain was between the initial 
chilled side and the second side temporal injection starting 
unchilled. Once the second side was chilled, the patients 
experienced pain relief from the skin cooling. Interestingly, 
one control patient mentioned they desired to have some pain 
reduction, and 68% of patients stated that the cooling reduced 
their fear of future injections. This factor is key, as patients 
may be more receptive to other procedures in the future 
if their fear is reduced. Finally, 24 hours afterward, 17/19 
treated patients responded that they would prefer treatment, 
Table  2  Patient  response  to  the  question  of  whether  they 
preferred treatment
Patient Age Sex Diagnosis Treated/ 
untreated
1 67 F FL Treated
2 64 M FL, PL N/A
3 65 F FL, Lipo, PL Treated
4 62 F FL, PL, CO2 N/A
5 67 F FL, PL, Lipo, CO2 N/A
6 58 F FL, Lipo, PL, CO2 Treated
7 57 F FL, Lipo, PL, CO2 Treated
8 71 F FL, Lipo, PL, CO2 N/A
9 56 F FL, PL, CO2 Treated
10 59 F FL, CO2 Treated
11 57 F FL, Lipo, PL Treated
12 71 F FL Treated
13 47 F FL, Lipo, PL Treated
14 64 F FL, PL, Ue, CO2 Treated
15 63 F FL, Lipo, PL Treated
16 76 F FL, Lipo, PL Treated
17 61 F FL, LaserLipo, PL Treated
18 74 F FL, PL, Lipo Treated
19 47 F FL, LaserLipo Treated
20 61 F FL, PL, Laserlipo Treated
21 55 F FL, PL, LaserLipo Treated
22 60 F FL, PL, laserLipo Treated
Notes: Nineteen patients underwent a rhytidectomy using CoolSkin® on the first 
side lateral injection. The second side was started without chilling. Three patients 
(highlighted in bold) experienced no chilling on either side of the face during their 
procedure. Patients received a survey asking for a 0–5 analog pain score for the 
treated  and  untreated  sides,  along  with  a  question  on  whether  they  preferred 
treatment, and a final question on whether the experience would reduce fears of 
future injections. Answers to whether they preferred treatment are shown. N/A 
represents  blank  survey  responses.  One  control  patient  stated  “treated”  as  a 
suggestion of future desire for pain reduction.
Abbreviations:  FL,  face  lift;  Lipo,  liposuction;  LaserLipo,  laser  liposuction;  PL, 
platymalplasty; Ue, upper eye blepharoplasty; CO2, fractional carbon dioxide laser 
resurfacing.
Table  3  Patient  response  to  the  question  of  whether  the 
CoolSkin® device reduced concerns about future injections
Patient Age Sex Diagnosis Yes/no
1 67 F FL Y
2 64 M FL, PL Y
3 65 F FL, Lipo, PL N
4 62 F FL, PL, CO2(Ue/Le) N
5 67 F FL, PL, Lipo, CO2 N*
6 58 F FL, Lipo, PL, CO2 N
7 57 F FL, Lipo, PL, CO2 Y
8 71 F FL, Lipo, PL, CO2 N*
9 56 F FL, PL, CO2 N*
10 59 F FL, CO2 Y
11 57 F FL, Lipo, PL Maybe
12 71 F FL Y
13 47 F FL, Lipo, PL Maybe
14 64 F FL, PL, Ue, CO2 N
15 63 F FL, Lipo, PL Y
16 76 F FL, Lipo, PL Y
17 61 F FL, LaserLipo, PL Y
18 74 F FL, PL, Lipo Y
19 47 F FL, LaserLipo Y
20 61 F FL, PL, Laserlipo Y
21 55 F FL, PL, Laserlipo Y
22 60 F FL, PL, Laserlipo Y
Notes: Nineteen patients underwent a rhytidectomy using CoolSkin® on the first 
side lateral injection. The second side was started without chilling. Three patients 
(highlighted in bold) experienced no chilling on either side of the face during their 
procedure. Patients received a survey asking for a 0–5 analog pain score for the treated 
and untreated sides, along with a question on whether they preferred treatment, and 
a final question on whether the experience would reduce fears of future injections. 
Answers to whether their fear of injection was reduced are shown.
Abbreviations: FL, face lift; Laser Lipo, laser liposuction; PL, platymalplasty; Ue, 
upper eye blepharoplasty; CO2, fractional carbon dioxide laser resurfacing.Journal of Pain Research
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with two failing to answer the question. These two patients, 
however, did want to be chilled on the second side.
While future studies with higher patient numbers will be 
needed, it was found that the central neck injections seemed 
more resistant to pain reduction. The two patients in this 
study preferred being treated with the device, but the impact 
seemed less. The patient who received botulism toxin who 
was treated with the CoolSkin device had pain reduction 
similar to those in previous studies14 using the device.
In summary, the CoolSkin device is a safe and effec-
tive tool for lateral pain reduction during rhytidectomy 
  injections. The device is well tolerated by patients with no 
flap loss at -4°C.
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Table 4 Response to questions from additional three patients
Patient Age Sex Diagnosis Cooled side  
score
Control side   
score
Pain scores after injections for lifestyle lift procedures
23 62 F LaserLipo 3 3
Patient Age Sex Diagnosis Yes/No
Did treated side reduce concerns of future injections?
23 62 F LaserLipo Y
Patient Age Sex Diagnosis Treated/Untreated
If given a choice would you prefer to be treated or untreated?
23 62 F LaserLipo Treated
Notes: Three patients were evaluated for further study designs. The three patients 
had three unique procedures. For patients 23 and 25 with neck procedures, the 
right half of the neck was chilled and the left was not during injection. The patient 
who had botulism toxin had one side of the face chilled and the other unchilled using 
the split forehead protocol. Patients were asked the same three questions as the   
22 rhytidectomy patients. Questions and answers are shown.
Abbreviations: LaserLipo, laser liposuction; Botox, botulinum toxin.